![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » AstraZeneca, Iqvia Join Forces for COVID-19 Vaccine Trial
AstraZeneca, Iqvia Join Forces for COVID-19 Vaccine Trial
![COVID-19 Clinical Trial](https://www.fdanews.com/ext/resources/test/Drug-Images4/COVID-19-CLINICAL-TRIAL.gif?t=1585696642&width=430)
July 15, 2020
AstraZeneca has teamed up with Iqvia to accelerate clinical trials of its COVID-19 vaccine candidate AZD1222 using Iqvia’s clinical research.
The collaboration will leverage Iqvia’s Virtual Trial solutions and will include an expansive subject study, which is expected to begin enrolling this summer.
The effort is part of the U.S. government’s Operation Warp Speed initiative that aims to develop a COVID-19 vaccine by the end of the year.
Upcoming Events
-
21Oct